أعرض في EDS

P1.07-004 Updated Analysis of Phase II Study of HA-Irinotecan, a CD44-Targeting Formulation of Hyaluronic Acid and Irinotecan, in Small Cell Lung Cancer

التفاصيل البيبلوغرافية
العنوان: P1.07-004 Updated Analysis of Phase II Study of HA-Irinotecan, a CD44-Targeting Formulation of Hyaluronic Acid and Irinotecan, in Small Cell Lung Cancer
المؤلفون: D. Neil Watkins, Vinod Ganju, Beena Kumar, P.D. Midolo, Muhammad Alamgeer, Ben Markman, Peter Briggs
المصدر: Journal of Thoracic Oncology. 12:S697-S698
بيانات النشر: Elsevier BV, 2017.
سنة النشر: 2017
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, medicine.medical_treatment, Phases of clinical research, 02 engineering and technology, 030226 pharmacology & pharmacy, 03 medical and health sciences, Drug treatment, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Hyaluronic acid, medicine, biology, business.industry, CD44, 021001 nanoscience & nanotechnology, Radiation therapy, Irinotecan, chemistry, biology.protein, Non small cell, 0210 nano-technology, business, medicine.drug
تدمد: 1556-0864
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0e1145b977d455ef09b716e290e02a60Test
https://doi.org/10.1016/j.jtho.2016.11.915Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........0e1145b977d455ef09b716e290e02a60
قاعدة البيانات: OpenAIRE
الوصف
تدمد:15560864